CELCUITY INC. Ttl Fee Amt
CELCUITY INC. (CELC) had Ttl Fee Amt of $79.41 thousand as of 2026-06-05, per its 424B5 filed 2026-06-05.
Financial Statements › Notes
ffd:TtlFeeAmt · last filed 2026-06-05
- 2026-06-05: Ttl Fee Amt $79.41K.
- 2026-05-18: Ttl Fee Amt $60.47K.
| Period end | Ttl Fee Amt |
|---|---|
| 2026-06-05 | $79.41K 424B5 · filed 2026-06-05 |
| 2026-05-18 | $60.47K S-8 · filed 2026-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |